Back to Health

What Interacts With Lamivudine?

What Interacts With Lamivudine?
Bareback Guide 29 August 2026

Lamivudine has one of the cleanest interaction profiles of any medicine used in HIV care. There is one absolute rule and a short list of minor considerations.

Why does it interact so little?

Because it is cleared by the kidneys largely unchanged rather than being broken down by liver enzymes. Most significant interactions in HIV medicine involve CYP3A4, and lamivudine neither affects that enzyme nor is affected by it.

What is the absolute rule?

Never combine it with emtricitabine. The two are closely related cytidine analogues that work by the same mechanism, share the same resistance pathway and offer no benefit together. Taking both is duplication rather than intensification.

How does that happen?

Usually through a combination tablet containing one and a separate tablet containing the other, when a regimen is changed without the full list being reviewed. It is the single most important thing to check with lamivudine.

How would you spot it?

By reading the components of every tablet you take rather than the brand names. Both drugs appear in many products under different names, and knowing what is in yours is the only reliable protection.

What affects its levels?

Anything that significantly reduces kidney function, since that is how it is cleared. In practice this means the dose is adjusted for kidney impairment rather than specific drugs causing a problem.

What about trimethoprim?

Co-trimoxazole, which contains trimethoprim, can raise lamivudine levels by competing for the same renal transporter. This is usually clinically insignificant at normal doses and worth knowing if you are on both long term.

Does it interact with hormone therapy?

No, in either direction. Lamivudine does not affect oestradiol or testosterone levels, and hormone therapy does not reduce its effectiveness. Other components of a combination tablet may differ.

What about contraception?

No interaction with hormonal contraception. Again, the question is about the whole regimen, since some other antiretrovirals do affect it.

What about recreational drugs?

No pharmacological interaction. Lamivudine does not block the enzyme that clears MDMA, methamphetamine, mephedrone or ketamine, unlike boosted regimens containing ritonavir or cobicistat.

What about alcohol?

No direct interaction. The practical concerns are missed doses and vomiting, plus liver health generally for anyone with hepatitis B or C.

What about antacids and supplements?

Fine. Lamivudine is not bound by calcium, magnesium, iron or zinc, so no spacing is required. If your tablet contains an integrase inhibitor, that component does need spacing.

What about other HIV medicines?

Beyond the emtricitabine rule, lamivudine combines with essentially everything. That compatibility is precisely why it appears in so many products across every class.

What about hepatitis B treatment?

If you are being treated for hepatitis B and start HIV treatment, or the reverse, both teams need to know. Lamivudine covers both, and using it at the wrong dose for either is the error to avoid.

How do you check a combination?

The University of Liverpool interaction checker covers antiretrovirals against prescription, over-the-counter and recreational drugs. A clinic pharmacist will check without an appointment in a couple of minutes.

What should you tell prescribers?

Everything you take, and specifically the full component list of your HIV tablet rather than just its brand name. That is what allows anyone to spot a duplication.

Who should know what you take?

Any prescriber, any pharmacy, your dentist and any hospital team. None of them see your HIV record automatically, so nobody will flag an interaction with lamivudine unless you mention it. A photograph of your packaging makes this quicker.

What if an interaction cannot be avoided?

Sometimes another condition genuinely needs a clashing drug. The answer is usually to change the HIV regimen rather than leave the other condition untreated, and that is worth raising rather than accepting a compromise.

What about emergencies?

Emergency treatment should not be delayed to check an interaction. Tell the team what you take, let them treat you, and have the combination reviewed afterwards rather than declining necessary care.